Drug shortages homepage
Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.
A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.
A discontinuation means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug, permanently ceases the sale of the drug.
Tier 3 drug shortages are those that have the greatest potential impact on Canada's drug supply and health care system. Impact is based on low availability of alternative supplies, ingredients or therapies. The Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders, makes recommendations on the tier assignment of drug shortages. The TAC assessment includes:
- a review of the information gathered on the shortage issue, and
- a thorough discussion on its potential impact and next steps.
Below are the newest and most recently updated Shortage and Discontinuation reports. Alternatively, please visit the Tier 3 page to see current Tier 3 Drug Shortages and associated shortage or discontinuation reports.

LEGEND
!!T3 denotes an actual Tier 3 shortage/discontinuation
!T3 denotes an anticipated Tier 3 shortage/discontinuation
Shortage Reports
Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
---|---|---|---|---|---|---|
KALETRA | ABBVIE CORPORATION | Resolved | 100MG 400MG | Updated Report | 2022-05-26 | 159917 |
SALOFALK | APTALIS PHARMA CANADA ULC | Actual shortage | 1G | Updated Report | 2022-05-26 | 161258 |
ADMELOG | SANOFI-AVENTIS CANADA INC | Actual shortage | 100UNIT | Updated Report | 2022-05-26 | 160685 |
ROPIVACAINE HYDROCHLORIDE INJECTION USP | PFIZER CANADA ULC | Actual shortage | 10MG | Updated Report | 2022-05-25 | 158396 |
PROSTIN VR STERILE SOLUTION | PFIZER CANADA ULC | Resolved | 500MCG | Updated Report | 2022-05-25 | 154147 |
MYLAN-CLOBETASOL CREAM | MYLAN PHARMACEUTICALS ULC | Resolved | 0.05% | Updated Report | 2022-05-25 | 160856 |
MYLAN-NAPROXEN/ESOMEPRAZOLE MR | MYLAN PHARMACEUTICALS ULC | Actual shortage | 20MG 500MG | Updated Report | 2022-05-25 | 152651 |
MYLAN-TADALAFIL | MYLAN PHARMACEUTICALS ULC | Actual shortage | 20MG | Updated Report | 2022-05-25 | 152654 |
MYLAN-VARDENAFIL | MYLAN PHARMACEUTICALS ULC | Actual shortage | 10MG | Updated Report | 2022-05-25 | 157908 |
MYLAN-ATOVAQUONE/PROGUANIL | MYLAN PHARMACEUTICALS ULC | Anticipated shortage | 100MG 250MG | New Report | 2022-05-25 | 161243 |
Discontinuation Reports
Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
---|---|---|---|---|---|---|
SANDOZ METHYLPHENIDATE SR | SANDOZ CANADA INCORPORATED | Discontinued | 20MG | New Report | 2022-05-24 | 161221 |
SANDOZ TOPIRAMATE TABLETS | SANDOZ CANADA INCORPORATED | Discontinued | 200MG | New Report | 2022-05-24 | 161216 |
SANDOZ TOPIRAMATE TABLETS | SANDOZ CANADA INCORPORATED | Discontinued | 100MG | New Report | 2022-05-24 | 161211 |
SANDOZ TOPIRAMATE TABLETS | SANDOZ CANADA INCORPORATED | Discontinued | 25MG | New Report | 2022-05-24 | 161206 |
IMOVANE | SANOFI-AVENTIS CANADA INC | To be discontinued | 5.0MG | Updated Report | 2022-05-16 | 160688 |
HEPTOVIR | GLAXOSMITHKLINE INC | To be discontinued | 5MG | New Report | 2022-05-13 | 160503 |
HEPTOVIR | GLAXOSMITHKLINE INC | To be discontinued | 100MG | New Report | 2022-05-13 | 160500 |
APO-BICALUTAMIDE | APOTEX INC | Discontinued | 50MG | Updated Report | 2022-05-13 | 157376 |
ISOPTO CARPINE | NOVARTIS PHARMACEUTICALS CANADA INC | To be discontinued | 4% | New Report | 2022-05-11 | 160361 |
RITALIN 10MG | NOVARTIS PHARMACEUTICALS CANADA INC | Discontinued | 10MG | Updated Report | 2022-05-11 | 154449 |
VENTOLIN NEBULES P.F. - 5MG/2.5ML | GLAXOSMITHKLINE INC | To be discontinued | 5MG | Updated Report | 2022-05-11 | 130636 |
VENTOLIN NEBULES P.F. - 2.5MG/2.5ML | GLAXOSMITHKLINE INC | To be discontinued | 2.5MG | Updated Report | 2022-05-11 | 130633 |
ONDANSETRON INJECTION, USP | MYLAN PHARMACEUTICALS ULC | Discontinued | 2MG | New Report | 2022-05-11 | 160318 |
ONDANSETRON INJECTION, USP | MYLAN PHARMACEUTICALS ULC | Discontinued | 2MG | New Report | 2022-05-11 | 160323 |
INTEGRILIN | MERCK CANADA INC | To be discontinued | 2MG | Updated Report | 2022-05-10 | 155794 |
ZEPATIER | MERCK CANADA INC | To be discontinued | 100MG 50MG | Updated Report | 2022-05-06 | 158741 |
ZOSTAVAX II | MERCK CANADA INC | To be discontinued | 19400PFU | New Report | 2022-04-26 | 159386 |
DEXTROSE INJECTION USP | ICU MEDICAL CANADA INC | To be discontinued | 700MG | New Report | 2022-04-21 | 159241 |
CODEINE PHOSPHATE INJECTION USP | SANDOZ CANADA INCORPORATED | Discontinued | 30MG | New Report | 2022-04-20 | 159064 |
SANDOZ PIOGLITAZONE | SANDOZ CANADA INCORPORATED | Discontinued | 15MG | New Report | 2022-04-20 | 159061 |